BioSpace News Archive

Drug Development

AlzeCure Announces Positive Phase IIa Clinical Study Data in Neuropathic Pain with the Non-opioid ACD440

AlzeCure Pharma announced that the company has received positive data from the Phase IIa clinical study with the non-opioid drug candidate ACD440, which is developed against peripheral neuropathic pain.

May 24, 2023
·
6 min read
Deals

Pyxis Oncology to Acquire Apexigen

Pyxis Oncology, Inc. and Apexigen, Inc. announced a definitive agreement by which Pyxis Oncology will acquire Apexigen in an all-stock transaction for an implied value of $0.64 per Apexigen share.

May 24, 2023
·
15 min read
Business

Centene Corporation Announces New Chief Communications Officer

Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives, announced it has named Shannon T. Susko as its Senior Vice President and Chief Communications Officer.

May 24, 2023
·
9 min read
Business

Kamada Reports Strong First Quarter 2023 Financial Results; Reiterates Revenue and Profitability Guidance

Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company, with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced financial results for three months ended March 31, 2023.

May 24, 2023
·
20 min read
Business

CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update

CollPlant Biotechnologies today announced financial results for the first quarter ended March 31, 2023, and provided a corporate update on its programs.

May 24, 2023
·
20 min read
Business

Minaris Regenerative Medicine Streamlining Contract Manufacturing with Veeva Vault Quality Suite Applications

Veeva Systems (NYSE: VEEV) today announced that Minaris Regenerative Medicine selected Veeva Vault QualityDocs and Veeva Vault Training to advance its global quality operations.

May 24, 2023
·
4 min read
Biotech Beach

Glaukos Announces Participation in the William Blair Growth Stock Conference - May 24, 2023

Glaukos Corporation today announced that its management is scheduled to participate in the William Blair 43 rd Annual Growth Stock Conference on Wednesday, June 7, 2023, at 10:40 a.m. CT in Chicago, IL.

May 24, 2023
·
1 min read
Genetown

BeiGene to Present at Upcoming Investor Conferences - May 24, 2023

BeiGene today announced that the Company will participate in fireside chats at two upcoming investor conferences.

May 24, 2023
·
2 min read
Business

NurExone Reports First Quarter 2023 Financial Results and Provides Corporate Update

NurExone Biologic Inc. has released its financial results for the quarter ended March 31, 2023.

May 24, 2023
·
9 min read
Business

Phio Pharmaceuticals Announces Initiation of Collaborative Clinical Trial with PH-762, AgonOx’s Tumor Infiltrating Lymphocyte Program (AGX148) and Providence Cancer Institute

Phio Pharmaceuticals Corp. today announced its clinical development partner, AgonOx, Inc, in collaboration with Providence Cancer Institute, has completed the site initiation visit and can commence with patient accrual.

May 24, 2023
·
5 min read